Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Clinical usefulness of a timed overnight (8 hours) Urine Albumin (microalbumin) excretion in monitor-ing treatment in benign essential hypertension.

Oluwatowoju IO, Ajuluchukwu JN, Afonja OA.

Niger Postgrad Med J. 2014 Jun;21(2):177-80.

PMID:
25126874
[PubMed - indexed for MEDLINE]
2.

[Urinary albumin excretion during the night in essential arterial hypertension].

Redón J, Miralles A, Lurbe E, Pascual JM, Lozano JV.

Med Clin (Barc). 1995 Apr 29;104(16):608-11. Spanish.

PMID:
7752711
[PubMed - indexed for MEDLINE]
3.

The effect of anti-hypertensive therapy on urinary albumin excretion in Nigerian hypertensives.

Salako BL, Kadiri S, Fehintola FA, Akinkugbe OO.

West Afr J Med. 1999 Jul-Sep;18(3):170-4.

PMID:
10593151
[PubMed - indexed for MEDLINE]
4.

Circadian variation of urinary microalbumin excretion and ambulatory blood pressure in patients with essential hypertension.

Hishiki S, Tochikubo O, Miyajima E, Ishii M.

J Hypertens. 1998 Dec;16(12 Pt 2):2101-8.

PMID:
9886903
[PubMed - indexed for MEDLINE]
5.

[24-hour blood pressure monitoring and albumin excretion in urine in hypertension].

Stenehjem AE, Bulatov VA, Os I.

Tidsskr Nor Laegeforen. 2001 Jun 10;121(15):1806-10. Norwegian.

PMID:
11464686
[PubMed - indexed for MEDLINE]
Free Article
6.

Microalbuminuria in elderly hypertensives: reproducibility and relation to clinic and ambulatory blood pressure.

James MA, Fotherby MD, Potter JF.

J Hypertens. 1994 Mar;12(3):309-14.

PMID:
8021485
[PubMed - indexed for MEDLINE]
7.

[Microalbuminuria and urinary albumin excretion: clinical practice guidelines].

Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, Berrut G, Fauvel JP, Gin H, Nitenberg A, Renversez JC, Rusch E, Valensi P, Cordonnier D.

Nephrol Ther. 2007 Oct;3(6):384-91. Epub 2007 Aug 10. French.

PMID:
17919641
[PubMed - indexed for MEDLINE]
8.

Subpressor doses of angiotensin II do not increase albumin excretion in humans.

Erley CM, Grau C, Furian TC, Wolf S, Braun N, Risler T.

Clin Nephrol. 1996 Nov;46(5):312-8.

PMID:
8953120
[PubMed - indexed for MEDLINE]
9.

Microalbuminuria in essential hypertensives in treatment for hypertension.

Cruz HM, Cruzera AB, Cruz J.

Rev Hosp Clin Fac Med Sao Paulo. 1997 Sep-Oct;52(5):258-62.

PMID:
9595780
[PubMed - indexed for MEDLINE]
10.

The angiotensin II receptor antagonist telmisartan reduces urinary albumin excretion in patients with isolated systolic hypertension: results of a randomized, double-blind, placebo-controlled trial.

Vogt L, Navis G, Köster J, Manolis AJ, Reid JL, de Zeeuw D; Angiotensin II Receptor Antagonist Telmisartan Micardis in Isolated Systolic Hypertension (ARAMIS) Study Group.

J Hypertens. 2005 Nov;23(11):2055-61.

PMID:
16208149
[PubMed - indexed for MEDLINE]
11.

Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study.

Nielsen S, Schmitz A, Poulsen PL, Hansen KW, Mogensen CE.

Diabetes Care. 1995 Nov;18(11):1434-41.

PMID:
8722066
[PubMed - indexed for MEDLINE]
12.

Albuminuria and transferrinuria in essential hypertension. Effects of antihypertensive therapy.

Alli C, Lombardo M, Zanni D, Agrati AM, Cassani M, Granata S.

Am J Hypertens. 1996 Nov;9(11):1068-76.

PMID:
8931831
[PubMed - indexed for MEDLINE]
13.
14.

[Determination of urinary albumin excretion in arterial hypertension].

de la Sierra A, Divisón JA, Garrido P, Barbón A, Arístegui R; en representación de los investigadores SEVIMAB.

Rev Clin Esp. 2012 Apr;212(4):172-8. doi: 10.1016/j.rce.2011.09.010. Epub 2011 Dec 15. Spanish.

PMID:
22176929
[PubMed - indexed for MEDLINE]
15.

Effect of losartan on TGF-beta1 and urinary albumin excretion in patients with type 2 diabetes mellitus and microalbuminuria.

Esmatjes E, Flores L, Iñigo P, Lario S, Ruilope LM, Campistol JM.

Nephrol Dial Transplant. 2001;16 Suppl 1:90-3.

PMID:
11369831
[PubMed - indexed for MEDLINE]
Free Article
16.

Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.

Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Magrini F, Zanchetti A.

J Hum Hypertens. 2005 Jun;19(6):471-7.

PMID:
15744331
[PubMed - indexed for MEDLINE]
17.

Microalbuminuria and urinary albumin excretion: French clinical practice guidelines.

Halimi JM, Hadjadj S, Aboyans V, Allaert FA, Artigou JY, Beaufils M, Berrut G, Fauvel JP, Gin H, Nitenberg A, Renversez JC, Rusch E, Valensi P, Cordonnier D.

Diabetes Metab. 2007 Sep;33(4):303-9. Epub 2007 Aug 16.

PMID:
17702622
[PubMed - indexed for MEDLINE]
Free Article
18.

Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.

Dominguez LJ, Barbagallo M, Kattah W, Garcia D, Sowers JR.

Am J Hypertens. 1995 Aug;8(8):808-14.

PMID:
7576397
[PubMed - indexed for MEDLINE]
19.

Comparison of long-term therapeutic effect of an ACE inhibitor, temocapril, with that of a diuretic on microalbuminuria in non-diabetic essential hypertension.

Shionoiri H, Kosaka T, Kita E, Takizawa T, Takasaki I.

Hypertens Res. 2000 Nov;23(6):593-600.

PMID:
11131271
[PubMed - indexed for MEDLINE]
Free Article
20.

Reverse white-coat effect as an independent risk for microalbuminuria in treated hypertensive patients.

Kato T, Horio T, Tomiyama M, Kamide K, Nakamura S, Yoshihara F, Nakata H, Nakahama H, Kawano Y.

Nephrol Dial Transplant. 2007 Mar;22(3):911-6. Epub 2006 Dec 1.

PMID:
17142262
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk